We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insider buys are often watched closely among investors.
Insider purchases shouldn't be seen as an explicit buy signal, as many strict rules apply to them.
CHD, LLY, and VTRS have all seen their respective CEOs buy shares over the past month.
Investors closely monitor insider buys, as they can give hints surrounding the long-term picture.
But it’s critical to note that insiders have a longer holding period than most, and many strict rules apply to their transactions.
Recently, CEOs of several companies – Church & Dwight (CHD - Free Report) , Eli Lilly (LLY - Free Report) , and Viatris (VTRS - Free Report) – have made splashes, acquiring shares. Let’s take a closer look at the transactions for those interested in trading like the insiders.
CHD CEO Buys $500K Worth
Church & Dwight develops, manufactures, and markets a broad range of household, personal care, and specialty products. The CEO dove in near mid-August, purchasing roughly 5.5k CHD shares at an overall transaction cost of just over $500k.
As shown below, shares have outperformed big in 2025 so far, losing roughly 10%. Still, insiders have been busy buying the dip, with the green arrows circled in the chart representing net insider buying activity.
Image Source: Zacks Investment Research
LLY CEO Buys Post-Earnings Weakness
LLY shares have faced pressure in 2025 so far, down 5% overall and widely underperforming relative to the S&P 500. But shares have shown nice life off the post-earnings lows so far, with insiders also buying after selling all throughout the year.
As we can see below, net insider buying activity has finally shown up after a 2025 that was primarily packed with selling.
Image Source: Zacks Investment Research
VTRS Insiders Buy On Momentum
Viatris, a global healthcare company, boasts an extensive product portfolio that comprises more than a thousand approved molecules across a wide range of key therapeutic areas. CEO Scott Smith made a sizable purchase, acquiring 22k VTRS shares at an overall transaction cost of roughly $220k.
Like those above, VTRS shares have lagged the S&P 500 considerably in 2025, down roughly 12%. But as shown again, insiders have been busy scooping up shares at discounted levels.
Image Source: Zacks Investment Research
Bottom Line
Many investors closely monitor insider buys, seeking insights into the longer-term picture. The transactions shouldn’t be relied on for near-term performance, as insiders’ holding periods are longer than most, and many strict rules apply.
Rather, investors can see insider buys as an overall net positive concerning the longer-term outlook.
All large-cap stocks above – Church & Dwight (CHD - Free Report) , Eli Lilly (LLY - Free Report) , and Viatris (VTRS - Free Report) – have seen their respective CEOs make purchases over the last month.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Insider Watch: 3 CEOs Buying the Dip
Key Takeaways
Investors closely monitor insider buys, as they can give hints surrounding the long-term picture.
But it’s critical to note that insiders have a longer holding period than most, and many strict rules apply to their transactions.
Recently, CEOs of several companies – Church & Dwight (CHD - Free Report) , Eli Lilly (LLY - Free Report) , and Viatris (VTRS - Free Report) – have made splashes, acquiring shares. Let’s take a closer look at the transactions for those interested in trading like the insiders.
CHD CEO Buys $500K Worth
Church & Dwight develops, manufactures, and markets a broad range of household, personal care, and specialty products. The CEO dove in near mid-August, purchasing roughly 5.5k CHD shares at an overall transaction cost of just over $500k.
As shown below, shares have outperformed big in 2025 so far, losing roughly 10%. Still, insiders have been busy buying the dip, with the green arrows circled in the chart representing net insider buying activity.
Image Source: Zacks Investment Research
LLY CEO Buys Post-Earnings Weakness
LLY shares have faced pressure in 2025 so far, down 5% overall and widely underperforming relative to the S&P 500. But shares have shown nice life off the post-earnings lows so far, with insiders also buying after selling all throughout the year.
As we can see below, net insider buying activity has finally shown up after a 2025 that was primarily packed with selling.
Image Source: Zacks Investment Research
VTRS Insiders Buy On Momentum
Viatris, a global healthcare company, boasts an extensive product portfolio that comprises more than a thousand approved molecules across a wide range of key therapeutic areas. CEO Scott Smith made a sizable purchase, acquiring 22k VTRS shares at an overall transaction cost of roughly $220k.
Like those above, VTRS shares have lagged the S&P 500 considerably in 2025, down roughly 12%. But as shown again, insiders have been busy scooping up shares at discounted levels.
Image Source: Zacks Investment Research
Bottom Line
Many investors closely monitor insider buys, seeking insights into the longer-term picture. The transactions shouldn’t be relied on for near-term performance, as insiders’ holding periods are longer than most, and many strict rules apply.
Rather, investors can see insider buys as an overall net positive concerning the longer-term outlook.
All large-cap stocks above – Church & Dwight (CHD - Free Report) , Eli Lilly (LLY - Free Report) , and Viatris (VTRS - Free Report) – have seen their respective CEOs make purchases over the last month.